Growing Geriatric Demographics Fueling Advancements In The Gastric Volvulus Treatment Market: Strengthening the Growth Trajectory of the Gastric Volvulus Treatment Market

"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Is the Expected CAGR for the Gastric Volvulus Treatment Market Through 2025?
Over the past few years, the market size for gastric volvulus treatment has seen significant expansion. Anticipated growth from $27.36 billion in 2024 to $28.95 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%, is expected. The growth experienced in the past can be credited to factors such as progress in surgical methods, enhancement in diagnostic technology, educational awareness programs, increase in minimally invasive procedures, and extensive research and clinical studies.

What's the Projected Size of the Global Gastric Volvulus Treatment Market by 2029?
Anticipated to witness robust expansion in the forthcoming years, the gastric volvulus treatment market is projected to escalate to $37.48 billion by 2029, with a compound annual growth rate (CAGR) of 6.7%. The projected growth within this period can be traced back to regulatory shifts and approvals, advancements in surgical methods, an increase in the aging population, personalized treatment programmes, and the use of high-tech imaging methods. The expected trends in this period entail minimally invasive surgical tactics, education and early treatment, investigation in various treatment methods, cooperative medical practices, and tailored treatment strategies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Top Growth Drivers in the Gastric Volvulus Treatment Industry: What's Accelerating the Market?
The increasing number of elderly people is predicted to fuel the expansion of the gastric volvulus treatment market. The term geriatric population pertains to individuals aged 65 and above. These elderly individuals are prone to various illnesses due to weakened immunity and advanced age. Gastric volvulus, in particular, tends to affect adults over 50 years of age. Consequently, a surge in the geriatric demographic is predicted to boost the market. For example, in January 2024, statistics released by the Population Reference Bureau (PRB), a nonprofit organization based in the US, predicted that the count of Americans aged 65 and older will rise from 58 million in 2022 to 82 million in 2050, marking a 47% increase. Similarly, their percentage of the total population will rise from 17% to 23%. Thus, the growth in geriatric populations is a key force propelling the gastric volvulus treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

What Trends Will Shape the Gastric Volvulus Treatment Market Through 2029 and Beyond?
Product advancements are emerging as a predominant trend in the gastric volvulus treatment sector. Top-tier firms in the industry are launching groundbreaking products to maintain their standing in the market. For example, Pfizer Inc., an American pharmaceutical establishment, disclosed in October 2023 that the U.S Food and Drug Administration (FDA) bestowed approval to VELSIPITY (etrasimod). This product, a once-daily sphingosine-1-phosphate (S1P) receptor activator, is designed for those with medium to extreme active ulcerative colitis (UC). VELSIPITY is recommended at a dosage of 2 mg. It encourages UC patients, who have moderate to high severity, to achieve a steroid-free resolution using a daily oral pill that offers a gratifying benefit-risk balance. The FDA's sanction of VELSIPITY marks a significant milestone for UC patients in need of innovative treatments for their long-standing condition and are primed to initiate advanced therapy.

What Are the Main Segments in the Gastric Volvulus Treatment Market?
The gastric volvulus treatment market covered in this report is segmented -

1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus
2) By Treatment Type: Medication, Surgery
3) By Route Of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:
1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy, Other Treatment Methods
2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques, Other Treatment Approaches

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9382&type=smp

Which Top Companies are Driving Growth in the Gastric Volvulus Treatment Market?
Major companies operating in the gastric volvulus treatment market include PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc

Which Regions Will Dominate the Gastric Volvulus Treatment Market Through 2029?
North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9382

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Contact Us:
The Business Research Company
Europe - +44 7882 955267
Asia: +91 88972 63534
Americas - +1 310-496-7795
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.